Pharmaceutical treatment options for chronic pain remain limited. Recent alarming opioid addiction rates, mortality, and modest or inadequate efficacy for some pain conditions have compelled the biomedicine community to create safer pharmaceutical alternatives.
One such alternative is medicinal cannabis. This article will explore how it can enhance traditional pharmacologic treatments and offer significant clinical advantages for patients.
Cognitive Behavioral Therapy
CBT is a type of psychotherapy that can help you learn to recognize unhelpful thoughts and behaviors. It can be used alone or with other treatments and lifestyle changes. It is typically a short-term process ranging from 6-20 sessions. Research shows that CBT is as effective or more effective than other bona fide therapies when comparing head-to-head.
For example, a person who experiences cancer pain might try to decrease stress levels and improve their coping skills by practicing relaxation techniques. They could also use CBT to change their negative thought patterns and behaviors that contribute to the pain and stress they experience.
A recent study showed that a synthetic cannabinoid suppressed CIPN symptoms in rats and humans (Spigelman, 2018). This pharmacological profile suggests that cannabis can be used as adjunctive therapy to reduce opioid doses and improve outcomes for CNCP. Further clinical trials with a rigorous approach to monitoring compliance and risk of harm are required, including urine drug screens as part of long-term CNCP medication management.
CBC has similar sedative qualities to THC but without any psychoactive properties. It is found in the hemp plant Rhododendron anthopogonoides, which also produces CBD and many other medicinal phytochemicals like aromatic terpenes. Scientists know little about CBC and how it works but think it increases the entourage effect in CBD products when combined. It is often found in tinctures and oils and used in CBD vape oil products because it can prevent crystallization and extend the shelf life of these products.
During the 5-week treatment period, participants completed online questionnaires that assessed their mood and anxiety and an electronic sleep diary. The researchers randomly assigned participants to single-session SH or CBT Cannabinoid (CBT-C). Sleep diaries indicated that the CBT-C group was significantly more effective in reducing insomnia symptoms than the control condition, even among those who reported using alcohol and cannabis for sleep regularly.
CBT’s molecular structure makes it similar to THC, but unlike THC, it doesn’t have psychoactive properties. Its effects are mainly related to its ability to promote sleep and relieve stress. Many people seek out hemp products with CBT in them for this purpose. CBT is found in tinctures but can also be extracted as an isolate or concentrate. Generally, it is mixed with CBD and other hemp cannabinoids to make a product suitable for consumption via oil rigs or vaporizers.
Medicinal cannabis is rapidly becoming an alternative to conventional pharmaceutical treatments for pain management. This is primarily due to the lack of success with opioids and their underlying risks. While current pharmaceutical therapies may offer some relief for some patients, they are ineffective and often expose patients to significant harm. Developing safer and more effective medicinal cannabis formulations is a high priority for the biomedicine community.
While the pharmacologic world has had some modest success with conventional analgesics for pain management, those treatments carry severe risks of addiction and overdose. This has driven the medical community to seek safer, more natural remedies.
Cannabis for pain management has gained increasing interest as a potential alternative to opioids for many patients who suffer from chronic pain.1
While THC and CBD may have received the most media attention, other cannabinoids like CBT and H4CBD are beginning to catch on. Fortunately, these cannabinoid extracts are also legal to consume in most states.
The critical difference between CBT and THC is that it does not cause psychoactive effects, which makes it a great addition to a pain-relieving hemp product. In addition, CBT is less prone to crystallization than THC, which makes it an ideal ingredient for vape oils and other CBD products. CBT also strengthens the entourage effect of other hemp compounds when mixed with them.